ROYALTY PHARMA PLC's ticker is and the CUSIP is G7709Q904. A total of 4 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,746,568 | +84.2% | 101,200 | +108.7% | 0.00% | 0.0% |
| Q2 2023 | $1,490,890 | -88.1% | 48,500 | -86.0% | 0.00% | -80.0% |
| Q1 2023 | $12,491,601 | -38.4% | 346,700 | -32.4% | 0.01% | -44.4% |
| Q4 2022 | $20,277,712 | -22.1% | 513,100 | -20.8% | 0.01% | -18.2% |
| Q3 2022 | $26,021,000 | +12.1% | 647,600 | +17.3% | 0.01% | +10.0% |
| Q2 2022 | $23,206,000 | – | 552,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANE STREET GROUP, LLC | 647,600 | $26,021,000 | 0.01% |
| SIMPLEX TRADING, LLC | 133,300 | $5,355,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 28,200 | $1,133,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |